RxDoctor Payments DataLook up a doctor →

Alireza Anissipour, DO

Orthopaedic Surgery of the Spine · Everett, WANPI 1033352968

Payments from drug & device makers

$661,991in general payments, 2019–2025

Across 1,056 payments — averaging $626.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$430K
  • Stryker$112K
  • Orthofix Medical, Inc.$100K
  • VB Spine LLC$18K
  • Si-bone, Inc.$410
  • Abbott$332
  • plus $615 from 7 others
$278,962in research payments, 2019–2025

Across 11 payments — averaging $25,360 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$263K
  • GS Solutions, Inc.$16K

What the payments were for

  • Royalty or licence$18,0193%
  • Consulting fees$243,91441%
  • Speaking & faculty fees$254,01342%
  • Travel & lodging$59,28810%
  • Food & beverage$22,7594%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$661,991 in reported general payments places this provider in the 95th percentile of 61 orthopaedic surgery of the spine providers in Washington.

See all orthopaedic surgery of the spine providers in Washington

Medicare billing

Part B allowed, 2024
$317,235
Medicare patients
208
Services billed
1,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol39$744
Gabapentin40$523
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen51$460
Methylprednisolone41$315
Oxycodone Hcl42$310
Ondansetron Hcl19$181
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$169
Cephalexin13$164
Hydromorphone Hcl17$142
Tizanidine Hcl13$109
Hydroxyzine Pamoate18$87
Meloxicam34$70
Tramadol Hcl13$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Everett

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →